Publication | Closed Access

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

AngiogenesisMedicineTissue InhibitorPathologyGynecologyMatrix Metalloproteinases 2Vascular BiologyOvarian CarcinomaOncologyTumor MicroenvironmentEndocrine-related CancerOvarian Cancer